Zymeworks Inc. Stock Toronto S.E.
Equities
ZYME
CA98985W1023
Biotechnology & Medical Research
Sales 2024 * | 95.49M 131M | Sales 2025 * | 107M 146M | Capitalization | 596M 815M |
---|---|---|---|---|---|
Net income 2024 * | -87M -119M | Net income 2025 * | -90M -123M | EV / Sales 2024 * | 5.45 x |
Net cash position 2024 * | 75.44M 103M | Net cash position 2025 * | 75.78M 104M | EV / Sales 2025 * | 4.86 x |
P/E ratio 2024 * |
-7.16
x | P/E ratio 2025 * |
-6.22
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.25% |
Latest transcript on Zymeworks Inc.
1st Jan change | Capi. | |
---|---|---|
+16.45% | 122B | |
+21.96% | 116B | |
+25.44% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.29% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |